Cargando…

Patent infections with soil-transmitted helminths and Schistosoma mansoni are not associated with increased prevalence of antibodies to the Onchocerca volvulus peptide epitopes OvMP-1 and OvMP-23

BACKGROUND: Ov16 serology is considered a reference method for Onchocerca volvulus epidemiological mapping. Given the suboptimal sensitivity of this test and the fact that seroconversion takes more than a year after infection, additional serological tests might be needed to guide onchocerciasis elim...

Descripción completa

Detalles Bibliográficos
Autores principales: Vlaminck, Johnny, Lagatie, Ole, Verheyen, Ann, Dana, Daniel, Van Dorst, Bieke, Mekonnen, Zeleke, Levecke, Bruno, Stuyver, Lieven J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6350367/
https://www.ncbi.nlm.nih.gov/pubmed/30691520
http://dx.doi.org/10.1186/s13071-019-3308-z
_version_ 1783390440255389696
author Vlaminck, Johnny
Lagatie, Ole
Verheyen, Ann
Dana, Daniel
Van Dorst, Bieke
Mekonnen, Zeleke
Levecke, Bruno
Stuyver, Lieven J.
author_facet Vlaminck, Johnny
Lagatie, Ole
Verheyen, Ann
Dana, Daniel
Van Dorst, Bieke
Mekonnen, Zeleke
Levecke, Bruno
Stuyver, Lieven J.
author_sort Vlaminck, Johnny
collection PubMed
description BACKGROUND: Ov16 serology is considered a reference method for Onchocerca volvulus epidemiological mapping. Given the suboptimal sensitivity of this test and the fact that seroconversion takes more than a year after infection, additional serological tests might be needed to guide onchocerciasis elimination programmes. Recently, two linear epitopes encoded in OvMP-1 and OvMP-23 peptides were introduced as serological markers, but the observed antibody cross-reactivity in samples originating from Onchocerca volvulus non-endemic areas required further investigation. METHODS: We evaluated both peptide markers in an O. volvulus hypo-endemic setting in Jimma Town, Ethiopia using peptide ELISA. For all individuals (n = 303), the infection status with soil-transmitted helminths and Schistosoma mansoni was known. RESULTS: We found that 11 (3.6%) individuals were positive for anti-Ov16 IgG4 antibodies, while 34 (11.2%) and 15 (5.0%) individuals were positive for OvMP-1 and OvMP-23, respectively. Out of the 34 OvMP-1 positive samples, 33 were negative on the Ov16 IgG4 ELISA. Similarly, out of the 15 OvMP-23 positive samples, 14 scored negative on this reference method. No difference in seroprevalence for all three markers could be observed between uninfected individuals and individuals infected with different soil-transmitted helminths or S. mansoni. Moreover, the intensity of the response to OvMP-1, OvMP-23 or Ov16 was not significantly stronger in individuals carrying patent STH or S. mansoni infections, nor was there any correlation between the intensities of the responses to the three different antigens. CONCLUSIONS: This study demonstrates that a patent infection with either soil-transmitted helminths or S. mansoni does not lead to increased antibody recognition of both OvMP-1 and OvMP23. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13071-019-3308-z) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6350367
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-63503672019-02-04 Patent infections with soil-transmitted helminths and Schistosoma mansoni are not associated with increased prevalence of antibodies to the Onchocerca volvulus peptide epitopes OvMP-1 and OvMP-23 Vlaminck, Johnny Lagatie, Ole Verheyen, Ann Dana, Daniel Van Dorst, Bieke Mekonnen, Zeleke Levecke, Bruno Stuyver, Lieven J. Parasit Vectors Research BACKGROUND: Ov16 serology is considered a reference method for Onchocerca volvulus epidemiological mapping. Given the suboptimal sensitivity of this test and the fact that seroconversion takes more than a year after infection, additional serological tests might be needed to guide onchocerciasis elimination programmes. Recently, two linear epitopes encoded in OvMP-1 and OvMP-23 peptides were introduced as serological markers, but the observed antibody cross-reactivity in samples originating from Onchocerca volvulus non-endemic areas required further investigation. METHODS: We evaluated both peptide markers in an O. volvulus hypo-endemic setting in Jimma Town, Ethiopia using peptide ELISA. For all individuals (n = 303), the infection status with soil-transmitted helminths and Schistosoma mansoni was known. RESULTS: We found that 11 (3.6%) individuals were positive for anti-Ov16 IgG4 antibodies, while 34 (11.2%) and 15 (5.0%) individuals were positive for OvMP-1 and OvMP-23, respectively. Out of the 34 OvMP-1 positive samples, 33 were negative on the Ov16 IgG4 ELISA. Similarly, out of the 15 OvMP-23 positive samples, 14 scored negative on this reference method. No difference in seroprevalence for all three markers could be observed between uninfected individuals and individuals infected with different soil-transmitted helminths or S. mansoni. Moreover, the intensity of the response to OvMP-1, OvMP-23 or Ov16 was not significantly stronger in individuals carrying patent STH or S. mansoni infections, nor was there any correlation between the intensities of the responses to the three different antigens. CONCLUSIONS: This study demonstrates that a patent infection with either soil-transmitted helminths or S. mansoni does not lead to increased antibody recognition of both OvMP-1 and OvMP23. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13071-019-3308-z) contains supplementary material, which is available to authorized users. BioMed Central 2019-01-28 /pmc/articles/PMC6350367/ /pubmed/30691520 http://dx.doi.org/10.1186/s13071-019-3308-z Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Vlaminck, Johnny
Lagatie, Ole
Verheyen, Ann
Dana, Daniel
Van Dorst, Bieke
Mekonnen, Zeleke
Levecke, Bruno
Stuyver, Lieven J.
Patent infections with soil-transmitted helminths and Schistosoma mansoni are not associated with increased prevalence of antibodies to the Onchocerca volvulus peptide epitopes OvMP-1 and OvMP-23
title Patent infections with soil-transmitted helminths and Schistosoma mansoni are not associated with increased prevalence of antibodies to the Onchocerca volvulus peptide epitopes OvMP-1 and OvMP-23
title_full Patent infections with soil-transmitted helminths and Schistosoma mansoni are not associated with increased prevalence of antibodies to the Onchocerca volvulus peptide epitopes OvMP-1 and OvMP-23
title_fullStr Patent infections with soil-transmitted helminths and Schistosoma mansoni are not associated with increased prevalence of antibodies to the Onchocerca volvulus peptide epitopes OvMP-1 and OvMP-23
title_full_unstemmed Patent infections with soil-transmitted helminths and Schistosoma mansoni are not associated with increased prevalence of antibodies to the Onchocerca volvulus peptide epitopes OvMP-1 and OvMP-23
title_short Patent infections with soil-transmitted helminths and Schistosoma mansoni are not associated with increased prevalence of antibodies to the Onchocerca volvulus peptide epitopes OvMP-1 and OvMP-23
title_sort patent infections with soil-transmitted helminths and schistosoma mansoni are not associated with increased prevalence of antibodies to the onchocerca volvulus peptide epitopes ovmp-1 and ovmp-23
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6350367/
https://www.ncbi.nlm.nih.gov/pubmed/30691520
http://dx.doi.org/10.1186/s13071-019-3308-z
work_keys_str_mv AT vlaminckjohnny patentinfectionswithsoiltransmittedhelminthsandschistosomamansoniarenotassociatedwithincreasedprevalenceofantibodiestotheonchocercavolvuluspeptideepitopesovmp1andovmp23
AT lagatieole patentinfectionswithsoiltransmittedhelminthsandschistosomamansoniarenotassociatedwithincreasedprevalenceofantibodiestotheonchocercavolvuluspeptideepitopesovmp1andovmp23
AT verheyenann patentinfectionswithsoiltransmittedhelminthsandschistosomamansoniarenotassociatedwithincreasedprevalenceofantibodiestotheonchocercavolvuluspeptideepitopesovmp1andovmp23
AT danadaniel patentinfectionswithsoiltransmittedhelminthsandschistosomamansoniarenotassociatedwithincreasedprevalenceofantibodiestotheonchocercavolvuluspeptideepitopesovmp1andovmp23
AT vandorstbieke patentinfectionswithsoiltransmittedhelminthsandschistosomamansoniarenotassociatedwithincreasedprevalenceofantibodiestotheonchocercavolvuluspeptideepitopesovmp1andovmp23
AT mekonnenzeleke patentinfectionswithsoiltransmittedhelminthsandschistosomamansoniarenotassociatedwithincreasedprevalenceofantibodiestotheonchocercavolvuluspeptideepitopesovmp1andovmp23
AT leveckebruno patentinfectionswithsoiltransmittedhelminthsandschistosomamansoniarenotassociatedwithincreasedprevalenceofantibodiestotheonchocercavolvuluspeptideepitopesovmp1andovmp23
AT stuyverlievenj patentinfectionswithsoiltransmittedhelminthsandschistosomamansoniarenotassociatedwithincreasedprevalenceofantibodiestotheonchocercavolvuluspeptideepitopesovmp1andovmp23